LTRN
Lantern Pharma·NASDAQ
--
--(--)
--
--(--)
6.97 / 10
Outperform
Fund flow metrics score 7.02/10, revealing robust fund flow characteristics. Beneficial Small trends are challenged by problematic overall, block, Medium, Large, and Extra-large signals, indicating positive capital movement. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 1 research evaluations, supported by 6.93 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-04-02
InstitutionLake Street
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of LTRN?
- LTRN holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.97/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
